News
Researchers create programmable immune cells for next-generation cancer therapy
Researchers at the Masonic Cancer Center, University of Minnesota, including Martin Felices, PhD, Jeffrey S.
Lung cancer screening rates rise nationwide, including in Minnesota
A new national report published in JAMA Internal Medicine found that lung cancer screening participation increased between 2022 and 2024, with encouraging gains seen across many populations and states. Among racial and ethnic groups,…
Welcoming Denise Windenburg as Director of the Minnesota Cancer Clinical Trials Network
The Minnesota Cancer Clinical Trials Network (MNCCTN) is pleased to welcome Denise Windenburg, MHA, as its Director of Network Operations.Denise brings more than 25 years of experience in clinical research operations, with a career…
Beyond imaging: How blood-based biomarkers could refine prostate cancer treatment
For patients with advanced prostate cancer, treatment decisions are often made with incomplete information - leaving uncertainty about which therapies will work best.New therapies like 177Lu-PSMA-617, a targeted radioligand therapy, have…
Meeting communities where they are: Expanding access to colorectal cancer screening in Minnesota
The power of early detectionMarch is recognized as Colorectal Cancer Awareness Month, a time to highlight the importance of prevention, early detection, and equitable access to screening. Colorectal cancer remains one of the most…
Colorectal Cancer Awareness Month: Advancing research through clinical trials
Colorectal cancer is one of the most common cancers worldwide, but it is also one of the most preventable. Through screening, doctors can detect cancer early—when treatment is most effective—and in some cases prevent it entirely by…
How more than a decade of tobacco research is shaping the future of cancer prevention
Scientific progress is often described through breakthroughs, such as a new discovery, a promising treatment, or a policy shift. Yet behind nearly every meaningful advance lies something far less visible: steady, cumulative research…
The Clinical Trials Office: How clinical research is made possible
Long before a study opens to participation, months (sometimes years) of careful planning, review, and coordination is happening behind the scenes. Much of this work happens quietly, out of public view, but it is essential to the integrity…
MCC's Silvia Balbo is part of a global team to study cancer's greatest challenges
MCC program leader Silvia Balbo, also a University of Minnesota School of Public Health (SPH) professor, has been named a co-investigator on a newly-funded research team supported by Cancer Grand Challenges, a leading global…
Zooming in on a virus that can cause blood cancer
New research from the Masonic Cancer Center (MCC), University of Minnesota and the School of Dentistry is helping scientists better understand a virus linked to blood cancer. The study, recently published in Nature Communications,…